CD106 (VCAM-1) Monoclonal Antibody (429), FITC, eBioscience and 1 more item

Life Technologies Corporation was awarded a purchase order (PO-0486301) by the University of Virginia on September 30, 2026, with a cumulative contract value of $277. The award encompasses the procurement of specialized life science research materials to be delivered to Subhashis Banerjee at the University of Virginia in Virginia. The contract includes two distinct line items totaling two units: a CD106 (VCAM-1) Monoclonal Antibody (429) conjugated with Fluorescein Isothiocyanate (FITC) from eBioscience, valued at $86.65, and Mouse Tumor Necrosis Factor-alpha Recombinant Protein from PeproTech, valued at $190.65.

These reagents and biologics are standard components utilized in immunological research and cell biology applications. The monoclonal antibody serves as a research tool for identifying and analyzing vascular cell adhesion molecule-1 expression, while the recombinant protein provides a key cytokine for experimental protocols. As a University of Virginia procurement action, this contract award reflects the institution's acquisition of critical research materials necessary to support ongoing scientific investigations within its laboratories.